End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0025 USD | -37.50% | +150.00% | -99.60% |
Apr. 25 | Labcorp beats quarterly estimates on strong testing demand | RE |
Apr. 25 | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
Financials (USD)
Sales 2021 | 460M | Sales 2022 | 516M | Capitalization | 452M |
---|---|---|---|---|---|
Net income 2021 | -379M | Net income 2022 | -3.11B | EV / Sales 2021 | 8.98 x |
Net Debt 2021 | 679M | Net Debt 2022 | 1.2B | EV / Sales 2022 | 3.21 x |
P/E ratio 2021 |
-8.5
x | P/E ratio 2022 |
-0.14
x | Employees | 1,700 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.19% |
Latest transcript on Invitae Corporation
1 day | -37.50% | ||
1 week | +150.00% | ||
Current month | +150.00% | ||
1 month | +212.50% | ||
3 months | -86.34% | ||
6 months | -99.55% | ||
Current year | -99.60% |
Managers | Title | Age | Since |
---|---|---|---|
Kenneth Knight
CEO | Chief Executive Officer | 63 | 20-06-28 |
Ana Schrank
DFI | Director of Finance/CFO | - | 23-10-01 |
David Sholehvar
COO | Chief Operating Officer | 56 | Nov. 12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 15-11-03 | |
Randal Scott
CEO | Chief Executive Officer | 66 | 10-01-12 |
Eric Aguiar
BRD | Director/Board Member | 62 | 10-08-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.69% | 14 M€ | -3.17% | ||
0.63% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 0.0025 | -37.50% | 81,446 |
24-05-14 | 0.004 | +566.67% | 591,639 |
24-05-13 | 0.0006 | 0.00% | 41,412 |
24-05-10 | 0.0006 | -88.00% | 171,956 |
24-05-09 | 0.005 | +400.00% | 146,353 |
End-of-day quote OTC Markets, May 14, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-99.60% | 716K | |
-27.90% | 9.84B | |
-4.81% | 3.15B | |
+31.37% | 2.99B | |
-14.73% | 2.15B | |
-14.39% | 1.8B | |
+70.99% | 1.49B | |
+23.17% | 770M | |
-2.18% | 762M | |
+3.18% | 308M |
- Stock Market
- Equities
- NVTA.Q Stock